Analysis of knockout/knockin mice that express a mutant FasL lacking the intracellular domain

por Lückerath, K, Kirkin, V, Zörnig, M
Publicado en Cell Commun Signal (2009)

Palmitoylation of human FasL modulates its cell death-inducing function

por Guardiola-Serrano, F, Rossin, A, Cahuzac, N, Lückerath, K, Melzer, I, Mailfert, S, Marguet, D, Zörnig, M, Hueber, A-O
Publicado 2010

Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment – initial experience

por Werner, R. A., Lückerath, K., Schmid, J. S., Higuchi, T., Kreissl, M. C., Grelle, I., Reiners, C., Buck, A. K., Lapa, C.
Publicado en Sci Rep (2016)

Prognostic Value of Serum Tumor Markers in Medullary Thyroid Cancer Patients Undergoing Vandetanib Treatment

por Werner, R.A., Schmid, J.S., Muegge, D.O., Lückerath, K., Higuchi, T., Hänscheid, H., Grelle, I., Reiners, C., Herrmann, K., Buck, A.K., Lapa, C.
Publicado en Medicine (Baltimore) (2015)